U-CyTech Overview
- Founded
- 1999
- Status
- Private
- Employees
- 4
- Latest Deal Type
- Early Stage VC
- Investors
- 1
U-CyTech General Information
Description
Developer of biomedical products designed to offer immunoassays for human, monkey and rodent use. The company's products include cytokine enzyme-linked immunosorbent assay, T and B cell assays and enzyme-linked Immuno spot systems which are designed for the ex vivo detection of individual protein secreting cells, enabling clients to prepare efficient medicines for their biological researches.
Contact Information
Website
www.ucytech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- Yalelaan 48
- 3584 CM Utrecht
- Netherlands
+31 085 000 0000
U-CyTech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jan-1999 | Completed | Startup |
U-CyTech Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Peter Van der Meide Ph.D | Founder, Owner & Chief Executive Officer |
U-CyTech Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialU-CyTech Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Utrecht Holdings | Venture Capital | Minority | 000 0000 | 000000 0 |